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          Authors of papers published in Rock-
efeller University Press journals (    The 
Journal of Cell Biology    ,     The Journal 
of Experimental Medicine    , or     The 
Journal of General Physiology    ) now 
retain copyright to their published 
work. This permits authors to reuse 
their own work in any way, as long 
as they attribute it to the original 
publication. Third parties may use 
our published materials under a Cre-
ative Commons license, six months 
after publication.   
  In 1787, the Copyright Clause of 
the United States Constitution gave the 
United States Congress the power   “  To 
promote the Progress of Science and use-
ful Arts, by securing for limited Times 
to Authors and Inventors the exclusive 
Right to their respective Writings and 
Discoveries.  ”   For more than two centuries, 
however, authors of scientifi  c papers have 
been giving up that right. 
  Even before the United States ex-
isted, copyright law was introduced in 
Britain to protect authors from pub-
lishers  ’   monopoly on printed material. 
However, scientifi   c publishers twisted 
these laws to their advantage, usurping 
copyright from authors. 
  Preying on authors  ’   desire to pub-
lish, and thus their willingness to sign 
virtually any form placed in front of them, 
scientifi  c publishers have traditionally 
required authors to sign over the copy-
right to their work before publication. 
For authors, this arrangement was both 
positive and negative. On the positive 
side, the publisher defended against im-
proper use of the authors  ’   work; on the 
negative side, restrictions were placed on 
authors (and third parties) that limited 
the reuse of the published work. 
  At The Rockefeller University 
Press, we have followed this tradition in 
the past and obtained copyright from au-
thors as a condition of publication. Sev-
eral years ago, however, we recognized 
that the advent of the internet had irrevo-
cably changed the nature and mecha-
nisms of knowledge distribution, and we 
returned some of those rights to authors. 
Since July 2000, we have allowed our 
authors to freely distribute their pub-
lished work by posting the fi  nal, format-
ted PDF version on their own websites 
immediately after publication (  1  ). 
  With the growing demand for pub-
lic access to published data, we recently 
started depositing all of our content in 
PubMed Central. In a further step to en-
hance the utility of scientifi  c content, we 
have now decided to return copyright to 
our authors. In return, however, we re-
quire authors to make their work avail-
able for reuse by the public. Instead of 
relinquishing copyright, our authors will 
now provide us with a license to pub-
lish their work. This license, however, 
places no restrictions on how authors 
can reuse their own work; we only re-
quire them to attribute the work to its 
original publication.
[ID]FIG1[/ID] Six months after 
publication, third parties (that is, any-
one who is not an author) can use the 
material we publish under the terms 
of the Creative Commons Attribution-
Noncommercial-Share Alike 3.0 Unported 
License (http://creativecommons.org/
licenses/by-nc-sa/3.0). 
  What does this Creative Commons 
License mean? It means that our pub-
lished content will be open for reuse, dis-
tribution, data mining, etc., by anyone, as 
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long as   attribution   is made to the original 
work.   Share-alike   means that any subse-
quent distribution must follow the rules 
set out in this license.   Non-commercial  
means that published work can be reused 
without permission, as long as it is for 
noncommercial purposes. 
  We still believe in protecting our 
authors from commercial exploitation 
of their work. Commercial reuse of ma-
terial published in one of our journals 
will still require permission from the 
journal. Authors, on the other hand, can 
reuse their own material for any pur-
pose, including commercial profi  t,  as 
long as proper attribution is made. 
  Within the fi   rst six months after 
publication, the same terms of this li-
cense apply, with one exception: the cre-
ation of mirror sites containing all of, or 
a subset of, our content is prohibited dur-
ing that period. The Rockefeller Univer-
sity Press still derives essential revenue 
from journal subscriptions to content 
within the fi  rst six months, and thus we 
cannot risk the creation of a free mirror 
site during this time. 
  The Creative Commons License 
will apply retroactively to all work pub-
lished by The Rockefeller University 
Press before November 1, 2007; the li-
cense restricting the creation of mirror 
sites will apply to all work published 
within the last six months. Authors who 
previously assigned their copyright to 
the Press are now granted the right to 
use their own work in any way they like, 
as long as they acknowledge the origi-
nal publication. 
  We are pleased to fi  nally comply 
with the original spirit of copyright in our 
continuing effort to promote public access 
to the published biomedical literature. 
Full text of our new copyright 
policy is available here:
http://www.jcb.org/misc/terms.shtml.
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